Insiders Sell Globally as US Data Goes Dark

The most striking feature of this week's insider picture is what is missing. ORTEX's first-party SEC EDGAR Form 4 tables, the primary source for US open-market insider trades, are unavailable in the current environment. US insider activity cannot be reported with the required accuracy this session, and the vendor table covers non-US markets only.

On the non-US side, the latest vendor filings are dated 8 September. The dominant theme is selling. SUAL Partners, the main shareholder of RUSAL, disclosed a $331m sale of 495 million shares filed on 8 September, covering a trade on 24 August. That is the single largest disclosed transaction in the dataset. Fosun Pharma Industrial, the promoter group at Indian generic drugmaker Gland Pharma, filed two separate tranches totalling roughly $296m in sales during early September.

In South Korea, ROBOTIS CEO Kim Byeong Soo filed a $75m sale of 366,525 shares on the trade date itself, a comparatively fast disclosure. Private equity firm L Catterton filed a $94m exit from Italian cosmetics manufacturer Intercos.

On the buying side, meaningful open-market purchases from named executives were absent from the latest filing window. No C-level discretionary buys above $1m appeared in the vendor data for the period.

ORTEX's screening data flags AppLovin and CrowdStrike among US names with the heaviest insider selling momentum over one month, while Lennar shows the strongest buying signal by value. Full trade-level detail for those names requires the EDGAR tables, which were inaccessible this session.